|
US2913454A
(en)
*
|
1956-11-23 |
1959-11-17 |
Schenley Ind Inc |
Certain cycloalkanotriazoles, process and intermediates
|
|
US3723442A
(en)
*
|
1970-12-31 |
1973-03-27 |
Yoshitomi Pharmaceutical |
3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes
|
|
US3784551A
(en)
*
|
1971-07-08 |
1974-01-08 |
Yoshitomi Pharmaceutical |
2-oxo-1,4-dioxa-8-azaspiro (4.5) decanes and related compounds
|
|
US4350696A
(en)
*
|
1980-03-08 |
1982-09-21 |
Pfizer Inc. |
Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
|
|
AU557300B2
(en)
*
|
1982-03-16 |
1986-12-18 |
Farmitalia Carlo Erba S.P.A. |
Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
|
|
DE3445377A1
(de)
*
|
1983-12-23 |
1985-07-04 |
Sandoz-Patent-GmbH, 7850 Lörrach |
Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen
|
|
FI864875A0
(fi)
*
|
1986-11-28 |
1986-11-28 |
Orion Yhtymae Oy |
Nya farmakologiskt aktiva foereningar, dessa innehaollande kompositioner samt foerfarande och mellanprodukter foer anvaendning vid framstaellning av dessa.
|
|
YU213587A
(en)
*
|
1986-11-28 |
1989-06-30 |
Orion Yhtymae Oy |
Process for obtaining new pharmacologic active cateholic derivatives
|
|
US5283352A
(en)
*
|
1986-11-28 |
1994-02-01 |
Orion-Yhtyma Oy |
Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
|
|
US5272167A
(en)
*
|
1986-12-10 |
1993-12-21 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US5750532A
(en)
*
|
1986-12-10 |
1998-05-12 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US4851423A
(en)
*
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US5225402A
(en)
*
|
1989-02-10 |
1993-07-06 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
|
GB8904174D0
(en)
*
|
1989-02-23 |
1989-04-05 |
British Bio Technology |
Compounds
|
|
US5169850A
(en)
*
|
1990-01-22 |
1992-12-08 |
American Cyanamid Company |
N-(dialkylamino)methylene)-substituted pyrazolo(1,5-a)-pyrimidine-3-carboxamides and N-(dialkylamino)methylene-substituted-4,5-dihydropyrazolo-(1,5-a)-pyrimidine-3-carboxamides
|
|
US5290803A
(en)
*
|
1990-02-12 |
1994-03-01 |
The Center Of Innovative Technology |
Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
|
|
US5382680A
(en)
*
|
1990-12-07 |
1995-01-17 |
The Center For Innovative Technology |
Allosteric hemoglobin modifier compounds
|
|
US5705521A
(en)
*
|
1990-02-12 |
1998-01-06 |
The Center For Innovative Technology |
Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors
|
|
US5591892A
(en)
*
|
1990-02-12 |
1997-01-07 |
Center For Innovative Technology |
Allosteric modifiers of hemoglobin
|
|
US5432191A
(en)
*
|
1990-02-12 |
1995-07-11 |
The Center For Innovative Technology |
Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
|
|
US5731454A
(en)
*
|
1990-02-12 |
1998-03-24 |
Virginia Commonwealth University |
Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
|
|
US5677330A
(en)
*
|
1990-02-12 |
1997-10-14 |
The Center For Innovative Technology |
Medical uses of allosteric hemoglobin modifier compounds in patient care
|
|
US5049695A
(en)
*
|
1990-02-12 |
1991-09-17 |
Center For Innovative Technology |
Allosteric hemoglobin modifiers
|
|
US5648375A
(en)
*
|
1990-02-12 |
1997-07-15 |
Virginia Commonwealth University |
Use of hydrophobic compounds and anesthetics in combination with allosteric hemoglobin modifiers
|
|
US5122539A
(en)
*
|
1990-02-12 |
1992-06-16 |
Center For Innovative Technology |
Allosteric hemoglobin modifiers useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
|
|
US5872282A
(en)
*
|
1990-12-07 |
1999-02-16 |
Virginia Commonwealth University |
Allosteric modifiers of hemoglobin
|
|
FR2677984B1
(fr)
*
|
1991-06-21 |
1994-02-25 |
Elf Sanofi |
Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
|
US5260325A
(en)
*
|
1991-08-19 |
1993-11-09 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking tertiary amides
|
|
US5258407A
(en)
*
|
1991-12-31 |
1993-11-02 |
Sterling Winthrop Inc. |
3,4-disubstituted phenols-immunomodulating agents
|
|
US5356904A
(en)
*
|
1992-10-07 |
1994-10-18 |
Merck & Co., Inc. |
Carbostyril oxytocin receptor antagonists
|
|
ATE236164T1
(de)
*
|
1992-12-04 |
2003-04-15 |
Janssen Pharmaceutica Nv |
Antiallergische triazolobenzazepinderivate
|
|
US5571813A
(en)
*
|
1993-06-10 |
1996-11-05 |
Beiersdorf-Lilly Gmbh |
Fused pyrimidine compounds and their use as pharmaceuticals
|
|
US5395846A
(en)
*
|
1993-06-25 |
1995-03-07 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Amino Bi- and tri-carbocyclic aklane bis-aryl squalene synthase inhibitors
|
|
FR2708608B1
(fr)
*
|
1993-07-30 |
1995-10-27 |
Sanofi Sa |
Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
|
|
WO1995004720A2
(en)
*
|
1993-08-10 |
1995-02-16 |
Black James Foundation |
Gastrin and cck receptor ligands
|
|
US5674879A
(en)
*
|
1993-09-24 |
1997-10-07 |
G.D. Searle & Co. |
Compositions including and methods of using conformationally restricted angiotensin II antagonist
|
|
US5426105A
(en)
*
|
1993-09-24 |
1995-06-20 |
G.D. Searle & Co. |
Conformationally restricted angiotensin II antagonists
|
|
TW279860B
(enExample)
*
|
1993-11-12 |
1996-07-01 |
Ciba Geigy Ag |
|
|
GB9409150D0
(en)
*
|
1994-05-09 |
1994-06-29 |
Black James Foundation |
Cck and gastrin receptor ligands
|
|
US5795907A
(en)
*
|
1994-05-27 |
1998-08-18 |
James Black Foundation Limited |
Gastin and CCK receptor ligands
|
|
US5912260A
(en)
*
|
1994-05-27 |
1999-06-15 |
James Black Foundation Limited |
Gastrin and CCK antagonists
|
|
CN1200725A
(zh)
*
|
1995-08-30 |
1998-12-02 |
拜尔公司 |
酰基氨基水杨酰胺类化合物
|
|
FR2741878B1
(fr)
*
|
1995-12-01 |
1998-01-09 |
Cird Galderma |
Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations
|
|
TW359669B
(en)
*
|
1995-12-15 |
1999-06-01 |
Otsuka Pharma Co Ltd |
Benzazepine derivatives
|
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
|
IL132522A0
(en)
*
|
1997-04-22 |
2001-03-19 |
Cocensys Inc |
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and pharmaceutical compositions containing the same
|
|
US6506783B1
(en)
*
|
1997-05-16 |
2003-01-14 |
The Procter & Gamble Company |
Cancer treatments and pharmaceutical compositions therefor
|
|
US6521641B1
(en)
*
|
1998-10-08 |
2003-02-18 |
Allergan, Inc. |
Male anti-fertility agents
|
|
US6541477B2
(en)
*
|
1999-08-27 |
2003-04-01 |
Scios, Inc. |
Inhibitors of p38-a kinase
|
|
US6476057B1
(en)
*
|
1999-09-23 |
2002-11-05 |
G.D. Searle & Co. |
Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
|
|
SE0001899D0
(sv)
*
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
US6482829B2
(en)
*
|
2000-06-08 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor
|
|
US7129242B2
(en)
*
|
2000-12-06 |
2006-10-31 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
|
|
CA2480856A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Substituted aryl amides
|
|
KR100741231B1
(ko)
*
|
2002-07-29 |
2007-07-19 |
에프. 호프만-라 로슈 아게 |
신규 벤조다이옥솔
|
|
US7186735B2
(en)
*
|
2002-08-07 |
2007-03-06 |
Sanofi-Aventis Deutschland Gmbh |
Acylated arylcycloalkylamines and their use as pharmaceuticals
|
|
MXPA05004890A
(es)
*
|
2002-11-07 |
2005-07-22 |
Merck & Co Inc |
Derivados de fenilalanina como inhibidores de dipeptidilpeptidasa para el tratamiento o prevencion de diabetes.
|
|
WO2004056744A1
(en)
*
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
EP1603884A4
(en)
*
|
2003-02-28 |
2008-05-28 |
Encysive Pharmaceuticals Inc |
PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE AND NAPHTHALENE UROTENSIN II RECEPTOR ANTAGONISTS
|
|
US7320989B2
(en)
*
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
BRPI0407834A
(pt)
*
|
2003-02-28 |
2006-02-14 |
Teijin Pharma Ltd |
composto, processo para a manufatura do mesmo, composição, processo para a manufatura da mesma, método de tratamento ou prevenção de um distúrbio mediado por proteìna quinase em um indivìduo, uso de um composto, ensaio para determinar a atividade dos compostos, e, método de inibição da atividade ou função de uma proteìna quinase
|
|
US7700583B2
(en)
*
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
ATE455547T1
(de)
*
|
2003-04-11 |
2010-02-15 |
High Point Pharmaceuticals Llc |
Pharmazeutische verwendungen von kondensierten 1, 2,4-triazolen
|
|
US20070270408A1
(en)
*
|
2003-04-11 |
2007-11-22 |
Novo Nordisk A/S |
Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines
|
|
JP4629657B2
(ja)
*
|
2003-04-11 |
2011-02-09 |
ハイ・ポイント・ファーマスーティカルズ、エルエルシー |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１型化活性化合物
|
|
US20060094699A1
(en)
*
|
2003-04-11 |
2006-05-04 |
Kampen Gita Camilla T |
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
|
|
US7501405B2
(en)
*
|
2003-04-11 |
2009-03-10 |
High Point Pharmaceuticals, Llc |
Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
|
|
WO2005007621A2
(en)
*
|
2003-05-30 |
2005-01-27 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
|
EP1670460B1
(en)
*
|
2003-10-10 |
2014-11-26 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
|
US20050261302A1
(en)
*
|
2004-04-29 |
2005-11-24 |
Hoff Ethan D |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
|
|
WO2006016882A2
(en)
*
|
2004-07-08 |
2006-02-16 |
Ndsu Research Foundation |
Methods and materials for enhancing the effects of protein modulators
|
|
JP2008515956A
(ja)
*
|
2004-10-12 |
2008-05-15 |
ノボ ノルディスク アクティーゼルスカブ |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１型活性スピロ化合物
|
|
CA2594116A1
(en)
*
|
2005-01-05 |
2006-07-13 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
JP2009514818A
(ja)
*
|
2005-11-01 |
2009-04-09 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
置換アミドの製薬学的用途
|
|
CA2627307A1
(en)
*
|
2005-11-01 |
2007-05-10 |
Transtech Pharma, Inc. |
Pharmaceutical use of substituted amides
|
|
CA2646588A1
(en)
*
|
2006-03-21 |
2007-09-27 |
High Point Pharmaceuticals, Llc |
Adamantane derivatives for the treatment of the metabolic syndrome
|
|
EP2010479A1
(en)
*
|
2006-04-07 |
2009-01-07 |
High Point Pharmaceuticals, LLC |
11 beta-hydroxysteroid dehydrogenase type 1 active compounds
|
|
WO2008101885A1
(en)
*
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
WO2008101914A2
(en)
*
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2125704A1
(en)
*
|
2007-02-23 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
KR20100015414A
(ko)
*
|
2007-03-09 |
2010-02-12 |
하이 포인트 파마슈티칼스, 엘엘씨 |
히드록시스테로이드 탈수소효소 억제제로서 인돌- 및 벤즈이미다졸 아미드
|
|
JP2010522766A
(ja)
*
|
2007-03-28 |
2010-07-08 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
１１ベータ−ｈｓｄ１活性化合物
|
|
JP2010526777A
(ja)
*
|
2007-04-24 |
2010-08-05 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
置換アミドの医薬用途
|
|
AU2009316802B2
(en)
*
|
2008-11-21 |
2015-02-26 |
Vtv Therapeutics Llc |
Adamantyl benzamide compounds
|